Literature DB >> 12205259

Comparison of oral versus normal and high-dose rectal acetaminophen in the treatment of febrile children.

Dennis Scolnik1, Eran Kozer, Sheila Jacobson, Shelley Diamond, Nancy L Young.   

Abstract

OBJECTIVES: To compare the defervescent effect of high-dose rectal suppository acetaminophen with the recommended oral and rectal dosages and to evaluate acceptability of rectal acetaminophen.
METHODS: A randomized, controlled trial was performed in 70 patients aged 6 months to 6 years with fever > or =39 degrees C. Group A received rectal acetaminophen 15 mg/kg, group B received rectal acetaminophen 30 mg/kg, and group C received oral acetaminophen 15 mg/kg. Primary outcome was maximal change in temperature during the 3-hour study period after initial treatment.
RESULTS: There were 24 patients in group A, 23 in group B, and 23 in group C. There was no significant difference in temperature change between the groups during the 3 hours or in the maximum drop in temperature or final temperature. Visual analog scores for satisfaction of parents did not reveal any significant differences between the oral and rectal routes.
CONCLUSIONS: There was no difference between the temperature decrement in patients treated with 15 mg/kg oral acetaminophen and the same or double dose rectally. Thus, there seems to be no evidence to support the use of higher doses of rectal acetaminophen for the treatment of fever in children. The rectal route proved to be as acceptable as the oral among parents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205259     DOI: 10.1542/peds.110.3.553

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Fever: to treat or not to treat?

Authors:  Miguel Glatstein; Dennis Scolnik
Journal:  World J Pediatr       Date:  2008-12-23       Impact factor: 2.764

2.  Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate.

Authors:  Jacques Viljoen; Jakobus J Bergh; Lodewyk J Mienie; Hercullas F Kotze; Gisella Terre'Blanche
Journal:  Metab Brain Dis       Date:  2012-02-17       Impact factor: 3.584

3.  Enduring large use of acetaminophen suppositories for fever management in children: a national survey of French parents and healthcare professionals' practices.

Authors:  Nathalie Bertille; Elisabeth Fournier-Charrière; Gérard Pons; Babak Khoshnood; Martin Chalumeau
Journal:  Eur J Pediatr       Date:  2016-05-19       Impact factor: 3.183

4.  Antipyretic treatment of noninfectious fever in children with severe traumatic brain injury.

Authors:  Jonathon M Brown; Yuthana Udomphorn; Pilar Suz; Monica S Vavilala
Journal:  Childs Nerv Syst       Date:  2007-10-05       Impact factor: 1.475

Review 5.  Paracetamol: a focus for the general pediatrician.

Authors:  Pierluigi Marzuillo; Stefano Guarino; Egidio Barbi
Journal:  Eur J Pediatr       Date:  2013-12-28       Impact factor: 3.183

6.  Rectal diclofenac versus high-dose rectal acetaminophen in children: A randomized clinical trial.

Authors:  Houman Hashemian; Marzie Fallah Khodadoost
Journal:  Caspian J Intern Med       Date:  2021-03

7.  Equal antipyretic effectiveness of oral and rectal acetaminophen: a randomized controlled trial [ISRCTN11886401].

Authors:  Mona Nabulsi; Hala Tamim; Ramzi Sabra; Ziyad Mahfoud; Shadi Malaeb; Hadi Fakih; Mohammad Mikati
Journal:  BMC Pediatr       Date:  2005-09-06       Impact factor: 2.125

8.  Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases.

Authors:  E Kalmár; B Kormányos; G Szakonyi; G Dombi
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975

9.  Knowledge, attitudes and misconceptions of primary care physicians regarding fever in children: a cross sectional study.

Authors:  Figen Demir; Ozgur Sekreter
Journal:  Ital J Pediatr       Date:  2012-09-05       Impact factor: 2.638

10.  Rectal Diclofenac Versus Rectal Paracetamol: Comparison of Antipyretic Effectiveness in Children.

Authors:  Mohammad Reza Sharif; Mostafa Haji Rezaei; Marzieh Aalinezhad; Golbahareh Sarami; Masoud Rangraz
Journal:  Iran Red Crescent Med J       Date:  2016-01-13       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.